US Bancorp’s Kymera Therapeutics KYMR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $74.1K | Buy |
1,699
+575
| +51% | +$25.1K | ﹤0.01% | 2586 |
|
|
2025
Q1 | $30.8K | Sell |
1,124
-54
| -5% | -$1.48K | ﹤0.01% | 2971 |
|
|
2024
Q4 | $47.4K | Sell |
1,178
-287
| -20% | -$11.5K | ﹤0.01% | 2763 |
|
|
2024
Q3 | $69.3K | Sell |
1,465
-651
| -31% | -$30.8K | ﹤0.01% | 2571 |
|
|
2024
Q2 | $63.2K | Sell |
2,116
-949
| -31% | -$28.3K | ﹤0.01% | 2542 |
|
|
2024
Q1 | $123K | Buy |
3,065
+72
| +2% | +$2.89K | ﹤0.01% | 2247 |
|
|
2023
Q4 | $76.2K | Buy |
2,993
+2,698
| +915% | +$68.7K | ﹤0.01% | 2455 |
|
|
2023
Q3 | $4.1K | Sell |
295
-23
| -7% | -$320 | ﹤0.01% | 3480 |
|
|
2023
Q2 | $7.31K | Buy |
318
+23
| +8% | +$529 | ﹤0.01% | 3341 |
|
|
2023
Q1 | $8.74K | Hold |
295
| – | – | ﹤0.01% | 3319 |
|
|
2022
Q4 | $7.36K | Buy |
+295
| New | +$7.36K | ﹤0.01% | 3376 |
|
|
2022
Q2 | – | Sell |
-204
| Closed | -$9K | – | 4116 |
|
|
2022
Q1 | $9K | Buy |
+204
| New | +$9K | ﹤0.01% | 3393 |
|